All Articles

A new report reveals Manufacturing Execution Systems are no longer just operational tools, but strategic weapons for navigating labor shortages and supply chain chaos.

A new report reveals undiagnosed testosterone deficiency could cost the U.S. up to $525 billion, but the real story is about the millions of men being missed.

A new partnership between AI tech firm Game Your Game and entertainment venue GolfSuites signals a major shift, aiming to merge indoor play with outdoor data.

A new deal between Glance and Productsup solves a critical data bottleneck, making AI-driven 'agentic commerce' a scalable reality for enterprise brands.

Quebec's funding for Roche's Itovebi offers new hope for breast cancer patients, but its complex approval reveals a national struggle over drug costs and access.

With 2,000% growth and recent profitability, SafeRide Health isn't just a fast-growing company—it's a blueprint for fixing healthcare access with tech.

A new report reveals 89% of leaders delay key property decisions, costing billions. The problem isn't a lack of data, but a failure to act on it.

From clean-beauty data to sports equity analytics, the NWHM's 2026 honorees are not just making history—they are deploying new models to reshape it.

Beyond new features like hotel cancellation flexibility, HTS's summer update reveals a firm identity: a B2B tech engine powering global travel's bottom line.

With new PE backing and a CEO from Avanade, Quisitive's hire of Sean Corrales is a calculated bet on specialized expertise to win in the AI and cloud market.

A German milling system is crossing the Atlantic, carrying RenX Enterprises' ambition to shift from waste management to high-value engineered soil production.

An Inc. 5000 ranking is a data point, but for shipping platform Shippo, it signals a deeper trend: the quiet industrialization of e-commerce for everyone.

As Semtech prepares its Q2 earnings call, all eyes are on its performance in AI data centers and IoT. Will the results validate the market's bullish outlook?

Qventus's AI suite adds $17.1M in revenue by proactively treating patients, proving automation is no longer hype but a critical lifeline for modern healthcare.

Amex Ventures' strategic investment in Fazeshift signals a new era where AI agents don't just assist finance teams—they execute the work.

Vynca's spot on the Inc. 5000 isn't just a business win; it's a validation of a tech-driven, humane approach to serious illness care at scale.

LXMQ's partnership with Privaclave AI signals a major shift, embedding runtime data security into its credit decisioning OS from day one.

A new blood test for Alzheimer's from Spear Bio wins a top tech award. Its unprecedented sensitivity could revolutionize early detection and treatment.

With its second Inc. 5000 win, Fleetworthy's integrated platform strategy is proving to be the new standard for fleet readiness and a major market signal.

As schools face a fiscal cliff with federal funds gone, one company's free, hands-on tech tour reveals a new strategy for survival and market share.